Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1987 Jul 15;137(2):109–113.

The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection.

W J Boyko, M T Schechter, K J Craib, B Willoughby, B Douglas, P Sestak, W A McLeod, M O'Shaughnessey
PMCID: PMC1492614  PMID: 3647808

Abstract

In an ongoing prospective study of homosexual men conducted in Vancouver since November 1982, 87 cases of human immunodeficiency virus (HIV) seroconversion have been documented to date. Comparison of laboratory results obtained a mean of 4.9 months before and 5.4 months after the estimated date of seroconversion revealed that a significant increase in the serum IgG level (from 1149 to 1335 mg/dl on average) and in C1q binding (from 8.8% to 14.2% on average) was associated with early HIV infection (p less than 0.001). A marginally significant decrease in the ratio of helper to suppressor (CD4 to CD8) cells (from 1.55 to 1.29 on average) was also noted (p = 0.025). A marked decrease in absolute number of CD4 cells was not seen with seroconversion, which suggests that profound loss of these cells may be a long-term effect of HIV infection. The occurrence of symptoms (including fatigue, fever, night sweats, unintentional weight loss, diarrhea, joint pains, cough unrelated to smoking, shortness of breath, oral thrush, herpes zoster and rash) did not increase with seroconversion. This finding suggests that most cases of HIV seroconversion may be asymptomatic or associated with relatively minor symptoms. On the other hand, generalized lymphadenopathy was found to develop after HIV seroconversion in about 50% of cases.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berthier A., Chamaret S., Fauchet R., Fonlupt J., Genetet N., Gueguen M., Pommereuil M., Ruffault A., Montagnier L. Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in France. Lancet. 1986 Sep 13;2(8507):598–601. doi: 10.1016/s0140-6736(86)92427-x. [DOI] [PubMed] [Google Scholar]
  2. Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med. 1986 Apr 3;314(14):874–879. doi: 10.1056/NEJM198604033141403. [DOI] [PubMed] [Google Scholar]
  3. Boyko W. J., Schechter M. T., Craib K. J., Constance P., Nitz R., Fay S., McLeod A., O'Shaughnessy M. The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls. CMAJ. 1986 Oct 15;135(8):881–887. [PMC free article] [PubMed] [Google Scholar]
  4. Boyko W. J., Schechter M. T., Jeffries E., Douglas B., Maynard M., O'Shaughnessy M. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Can Med Assoc J. 1985 Jul 1;133(1):28–32. [PMC free article] [PubMed] [Google Scholar]
  5. Cooper D. A., Gold J., Maclean P., Donovan B., Finlayson R., Barnes T. G., Michelmore H. M., Brooke P., Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. doi: 10.1016/s0140-6736(85)91205-x. [DOI] [PubMed] [Google Scholar]
  6. Drew W. L., Mintz L., Miner R. C., Sands M., Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981 Feb;143(2):188–192. doi: 10.1093/infdis/143.2.188. [DOI] [PubMed] [Google Scholar]
  7. Euler H. H., Kern P., Löffler H., Dietrich M. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome. Clin Exp Immunol. 1985 Feb;59(2):267–275. [PMC free article] [PubMed] [Google Scholar]
  8. Ho D. D., Sarngadharan M. G., Resnick L., Dimarzoveronese F., Rota T. R., Hirsch M. S. Primary human T-lymphotropic virus type III infection. Ann Intern Med. 1985 Dec;103(6 ):880–883. doi: 10.7326/0003-4819-103-6-880. [DOI] [PubMed] [Google Scholar]
  9. Hutt-Fletcher L. M., Balachandran N., Elkins M. H. B cell activation by cytomegalovirus. J Exp Med. 1983 Dec 1;158(6):2171–2176. doi: 10.1084/jem.158.6.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lightfoote M. M., Folks T. M., Redfield R., Gold J., Sell K. W. Circulating IgA immune complexes in AIDS. Immunol Invest. 1985 Aug;14(4):341–345. doi: 10.3109/08820138509022669. [DOI] [PubMed] [Google Scholar]
  11. Mavligit G. M., Talpaz M., Hsia F. T., Wong W., Lichtiger B., Mansell P. W., Mumford D. M. Chronic immune stimulation by sperm alloantigens. Support for the hypothesis that spermatozoa induce immune dysregulation in homosexual males. JAMA. 1984 Jan 13;251(2):237–241. doi: 10.1001/jama.251.2.237. [DOI] [PubMed] [Google Scholar]
  12. McDougal J. S., Hubbard M., Nicholson J. K., Jones B. M., Holman R. C., Roberts J., Fishbein D. B., Jaffe H. W., Kaplan J. E., Spira T. J. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J Clin Immunol. 1985 Mar;5(2):130–138. doi: 10.1007/BF00915011. [DOI] [PubMed] [Google Scholar]
  13. Melbye M., Biggar R. J., Ebbesen P., Neuland C., Goedert J. J., Faber V., Lorenzen I., Skinhøj P., Gallo R. C., Blattner W. A. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med. 1986 Apr;104(4):496–500. doi: 10.7326/0003-4819-104-4-496. [DOI] [PubMed] [Google Scholar]
  14. Morrow W. J., Wharton M., Stricker R. B., Levy J. A. Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol. 1986 Sep;40(3):515–524. doi: 10.1016/0090-1229(86)90196-0. [DOI] [PubMed] [Google Scholar]
  15. Pahwa S., Pahwa R., Saxinger C., Gallo R. C., Good R. A. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8198–8202. doi: 10.1073/pnas.82.23.8198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Purtilo D. T., Kipscomb H., Krueger G., Sonnabend J., Casareale D., Volsky D. J. Role of Epstein-Barr virus in acquired immune deficiency syndrome. Adv Exp Med Biol. 1985;187:53–65. doi: 10.1007/978-1-4615-9430-7_5. [DOI] [PubMed] [Google Scholar]
  17. Rosén A., Gergely P., Jondal M., Klein G., Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature. 1977 May 5;267(5606):52–54. doi: 10.1038/267052a0. [DOI] [PubMed] [Google Scholar]
  18. Schechter M. T., Boyko W. J., Jeffries E., Willoughby B., Nitz R., Constance P. The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy. Can Med Assoc J. 1985 Jun 1;132(11):1273–1279. [PMC free article] [PubMed] [Google Scholar]
  19. Weber J. N., Wadsworth J., Rogers L. A., Moshtael O., Scott K., McManus T., Berrie E., Jeffries D. J., Harris J. R., Pinching A. J. Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet. 1986 May 24;1(8491):1179–1182. doi: 10.1016/s0140-6736(86)91160-8. [DOI] [PubMed] [Google Scholar]
  20. Williams R. C., Jr, Masur H., Spira T. J. Lymphocyte-reactive antibodies in acquired immune deficiency syndrome. J Clin Immunol. 1984 Mar;4(2):118–123. doi: 10.1007/BF00915045. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES